Katia Scotlandi
Laboratory of Oncologic Research
Orthopaedic Institute Rizzoli
Via di Barbiano 1/10
40136 Bologna
Italy
Name/email consistency: high
- Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. Scotlandi, K., Remondini, D., Castellani, G., Manara, M.C., Nardi, F., Cantiani, L., Francesconi, M., Mercuri, M., Caccuri, A.M., Serra, M., Knuutila, S., Picci, P. J. Clin. Oncol. (2009)
- Targeted therapies in bone sarcomas. Scotlandi, K., Picci, P., Kovar, H. Curr. Cancer. Drug. Targets (2009)
- Targeting insulin-like growth factor 1 receptor in sarcomas. Scotlandi, K., Picci, P. Curr. Opin. Oncol (2008)
- CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Scotlandi, K., Zuntini, M., Manara, M.C., Sciandra, M., Rocchi, A., Benini, S., Nicoletti, G., Bernard, G., Nanni, P., Lollini, P.L., Bernard, A., Picci, P. Oncogene (2007)
- Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma. Scotlandi, K., Perdichizzi, S., Bernard, G., Nicoletti, G., Nanni, P., Lollini, P.L., Curti, A., Manara, M.C., Benini, S., Bernard, A., Picci, P. Eur. J. Cancer (2006)
- Targeted therapies in Ewing's sarcoma. Scotlandi, K. Adv. Exp. Med. Biol. (2006)
- Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. Scotlandi, K., Manara, M.C., Nicoletti, G., Lollini, P.L., Lukas, S., Benini, S., Croci, S., Perdichizzi, S., Zambelli, D., Serra, M., García-Echeverría, C., Hofmann, F., Picci, P. Cancer Res. (2005)
- Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma. Scotlandi, K., Manara, M.C., Hattinger, C.M., Benini, S., Perdichizzi, S., Pasello, M., Bacci, G., Zanella, L., Bertoni, F., Picci, P., Serra, M. Eur. J. Cancer (2005)
- C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions. Scotlandi, K., Manara, M.C., Strammiello, R., Landuzzi, L., Benini, S., Perdichizzi, S., Serra, M., Astolfi, A., Nicoletti, G., Lollini, P.L., Bertoni, F., Nanni, P., Picci, P. J. Clin. Oncol. (2003)
- Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells. Scotlandi, K., Maini, C., Manara, M.C., Benini, S., Serra, M., Cerisano, V., Strammiello, R., Baldini, N., Lollini, P.L., Nanni, P., Nicoletti, G., Picci, P. Cancer Gene Ther. (2002)
- Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells. Scotlandi, K., Avnet, S., Benini, S., Manara, M.C., Serra, M., Cerisano, V., Perdichizzi, S., Lollini, P.L., De Giovanni, C., Landuzzi, L., Picci, P. Int. J. Cancer (2002)
- Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells. Scotlandi, K., Perdichizzi, S., Manara, M.C., Serra, M., Benini, S., Cerisano, V., Strammiello, R., Mercuri, M., Reverter-Branchat, G., Faircloth, G., D'Incalci, M., Picci, P. Clin. Cancer Res. (2002)
- CD99 engagement: an effective therapeutic strategy for Ewing tumors. Scotlandi, K., Baldini, N., Cerisano, V., Manara, M.C., Benini, S., Serra, M., Lollini, P.L., Nanni, P., Nicoletti, G., Bernard, G., Bernard, A., Picci, P. Cancer Res. (2000)
- Murine model for skeletal metastases of Ewing's sarcoma. Scotlandi, K., Benini, S., Manara, M.C., Serra, M., Nanni, P., Lollini, P.L., Nicoletti, G., Landuzzi, L., Chano, T., Picci, P., Baldini, N. J. Orthop. Res. (2000)
